Clinicogenomic Predictors Of Extreme Responses To Anti-Pd1/Pdl1 Checkpoint Inhibitors (Cpi) In Metastatic Urothelial Cancer (Muc).

JOURNAL OF CLINICAL ONCOLOGY(2020)

引用 0|浏览46
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要